
Wajd Life won a SAR 39.6M contract to operate medical services for a Saudi security agency, deepening its exposure to stable government-sector revenue.
Wajd Life Trading Co. won a SAR 39.6 million contract from the General Bureau of the Presidency of State Security, the company disclosed in a filing to the Saudi stock exchange on Sunday.
The project covers the operation of medical services and the maintenance of medical equipment for the bureau's medical centers. Wajd Life said there are no related parties involved in the award, which was signed on June 22.
The contract adds to Wajd Life's exposure to the government healthcare segment, a part of the market that typically carries multi-year terms and more predictable cash flows than private-sector hospital contracts. Government procurement in Saudi Arabia, especially from security agencies, often comes with lower credit risk and can serve as a reference for future bids in the same niche.
The company did not disclose the contract's duration or the expected revenue recognition schedule. Without those details, the immediate impact on Wajd Life's backlog and near-term revenue is unclear. The SAR 39.6 million sum is a meaningful addition given the company's market capitalization, though Wajd Life did not provide its total order book or prior-year revenue for comparison.
Wajd Life is a Riyadh-based firm that provides medical equipment, supplies, and healthcare services. It has listed on Tadawul since 2022 and has been building a track record of state-sector contracts. The award follows a string of smaller government deals the company has secured over the past two years.
Investors will need to wait for the company's next quarterly filing to see how this contract affects the revenue pipeline. The stock did not trade on the announcement because the news came after market hours. The contract's duration and margin profile will determine whether it is a one-time boost or a recurring income source.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.